Somerset Therapeutics Business History

History of Somerset Therapeutics

Established in 2015, Somerset Therapeutics develops, manufactures, and markets generic injectable and ophthalmic drugs.  The company’s executive team has considerable accomplishments:

  • Track record of successful commercial launches of over 300 drug products with revenues of $800 million
    • Savings to customers and patients exceeding $3 billion through quality generic products
  • Exceptional compliance record with the FDA and many other regulatory agencies (DEA, EPA, etc.)
    • No FDA warning letters 
    • Successful remediation of previous management’s warnings letters and consent decrees
  • Creation of 500 domestic scientific jobs and employment of 400 international scientific jobs
  • Establishing, growing, and developing multiple pharmaceutical firms which the ownership exited totaling $1.1 billion
  •  

The company is affiliated with Odin Pharmaceuticals, a development company which specializes in difficult-to-develop and difficult-to-manufacture sterile injectable and sterile ophthalmic products. 

Contact Us About Our Generics